Home / Contract Awards / Leidos to Help USAID Facilitate Malaria Vaccine R&D Projects; Jerry Hogge Comments

Leidos to Help USAID Facilitate Malaria Vaccine R&D Projects; Jerry Hogge Comments

LeidosLogoLeidos (NYSE: LDOS) has been awarded a potential five-year, $23.7 million contract to support the U.S. Agency for International Development‘s efforts to research and develop a vaccine against malaria.

The company said Monday it will provide scientific and management services for USAID’s Malaria Vaccine Development Program under the cost-plus-fixed-fee contract.

Jerry Hogge, Leidos health deputy group president, said the company brings decades of life sciences technology and experience to the USAID program.

Leidos said the work to occur in Frederick, Maryland, could also evaluate malaria vaccine candidates during preclinical studies and clinical and field trials.

The company’s life sciences team supports medical product R&D efforts at the National Institutes of Health and the departments of Defense and Homeland Security.

Check Also

Report: NGA Could Put $830M in FY 2019 Contracts Up for Competition

The National Geospatial-Intelligence Agency’s updated forecast for contracting opportunities shows that nine potential solicitations totaling …

USAF Awards Lockheed $172M Contract for Lot 2 Long-Range Anti-Ship Missiles

The U.S. Air Force has awarded Lockheed Martin (NYSE: LMT) a potential three-year, $172.1M to manufacture a …